Cargando…

Restoration of intestinal function in an MPTP model of Parkinson’s Disease

Patients with Parkinson’s disease often experience non-motor symptoms including constipation, which manifest prior to the onset of debilitating motor signs. Understanding the causes of these non-motor deficits and developing disease modifying therapeutic strategies has the potential to prevent disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellett, L. J., Hung, L. W., Munckton, R., Sherratt, N. A., Culvenor, J., Grubman, A., Furness, J. B., White, A. R., Finkelstein, D. I., Barnham, K. J., Lawson, V. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965866/ https://www.ncbi.nlm.nih.gov/pubmed/27471168 http://dx.doi.org/10.1038/srep30269

Ejemplares similares

Gene dysregulation is restored in the Parkinson’s disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm)
por: Cheng, Lesley, et al.
Publicado: (2016)

Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion
por: Castro-Hernández, Javier, et al.
Publicado: (2017)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
por: Tran, Katie K. N., et al.
Publicado: (2022)

ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
por: Diwakarla, Shanti, et al.
Publicado: (2021)

The hypoxia imaging agent Cu(II)(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
por: Hung, Lin W., et al.
Publicado: (2012)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Expression analysis of genes involved in mitochondrial biogenesis in mice with MPTP-induced model of Parkinson's disease
por: Rudenok, M.M., et al.
Publicado: (2020)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Restoration of MPTP-induced deficits by exercise and Milmed(®) co-treatment
por: Archer, Trevor, et al.
Publicado: (2014)

Parkinsonism as a Third Wave of the COVID-19 Pandemic?
por: Beauchamp, Leah C., et al.
Publicado: (2020)

Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota
por: Zhou, Xiaoting, et al.
Publicado: (2021)

A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson’s disease
por: Geldenhuys, Werner J., et al.
Publicado: (2015)

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease
por: Delamarre, Anna, et al.
Publicado: (2020)

MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.
por: Kopin, I J
Publicado: (1987)

ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022)

Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease
por: Ribeiro-Carvalho, A., et al.
Publicado: (2021)

Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson’s Disease
por: Seo, Min Hyung, et al.
Publicado: (2023)

Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease
por: Guo, Tong-Tong, et al.
Publicado: (2023)

Role of the MPTP in conditioning the heart – translatability and mechanism
por: Ong, S‐B, et al.
Publicado: (2015)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease
por: Rudenok, Margarita M., et al.
Publicado: (2022)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

MPTP-Treated Zebrafish Recapitulate ‘Late-Stage’ Parkinson’s-like Cognitive Decline
por: Bashirzade, Alim A. O., et al.
Publicado: (2022)

Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2017)

Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2020)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023)

Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson’s disease
por: Modo, Michel, et al.
Publicado: (2017)

Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease
por: Lauretti, E, et al.
Publicado: (2016)

Whole Transcriptome Analysis of Substantia Nigra in Mice with MPTP-Induced Parkinsonism Bearing Defective Glucocerebrosidase Activity
por: Usenko, Tatiana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b5977gms9mq1jdj2m1p9i6u3no